TABLE 2.
Pearson Correlations of Patients’ Characteristics and Functional Status with Spouses’ Distressa
| Patient variable | Spouses’ distress |
|
|---|---|---|
| General | Cancer-specific | |
| Gleason sum score | 0.10 | 0.07 |
| Pre-treatment PSA | 0.09 | 0.07 |
| Days post-treatmenta | 0.01 | 0.06 |
| Days post-diagnosis | 0.00 | 0.12 |
| No. of comorbid conditions | 0.00 | -0.02 |
| Urinary function | 0.03 | 0.08 |
| Sexual function | -0.03 | -0.01 |
| Bowel function | -0.12 | -0.26b |
| Urinary bother | -0.03 | -0.01 |
| Sexual bother | -0.11 | -0.13 |
| Bowel bother | -0.08 | -0.14 |
| Physical function | -0.11 | -0.06 |
| Role-physical function | 0.02 | -0.02 |
| General health | -0.04 | -0.11 |
| Body pain | -0.13 | -0.12 |
| Vitality | -0.08 | -0.12 |
| Social function | 0.02 | -0.13 |
| Role-emotional function | -0.14 | -0.18 |
| Mental health | -0.07 | -0.28b |
| General distress | 0.03 | 0.21c |
| Cancer-specific distress | 0.00 | 0.13 |
PSA: prostate-specific antigen.
a
Days since treatment initiation. N’s fluctuate due to missing data, (range, 162–165). Higher prostate-specific and general health-related quality of life scores indicate better functioning. General distress indicates the total score of the Center for Epidemiological Studies—Depression Scale (CES-D). Cancer-specific distress indicates the total score of the Impact of Events Scale (IES). Higher scores on the CES-D and IES indicate more distress.
b
P < 0.001.
c
P < 0.005.